Journal of Inorganic Biochemistry (J INORG BIOCHEM)
Description
Journal of Inorganic Biochemistry publishes research papers and short communications in the following areas: the chemistry, structure, and function of metalloenzymes; the interaction of inorganic ions and molecules with proteins and nucleic acids; the preparation and properties of coordination complexes of biological interest including both structural and functional model systems; the role of metal-containing systems in the regulation of gene expression; the application of spectroscopic methods to determine the structure of metallobiomolecules; the function of trace elements in living systems; and related subjects.
- Impact factor3.35Show impact factor historyImpact factorYear
- WebsiteJournal of Inorganic Biochemistry website
-
Other titlesJournal of inorganic biochemistry (Online)
-
ISSN0162-0134
-
OCLC39039411
-
Material typeDocument, Periodical, Internet resource
-
Document typeInternet Resource, Computer File, Journal / Magazine / Newspaper
Publisher details
-
Pre-print
- Author can archive a pre-print version
-
Post-print
- Author can archive a post-print version
-
Conditions
- Voluntary deposit by author of pre-print allowed on Institutions open scholarly website and pre-print servers
- Voluntary deposit by author of authors post-print allowed on institutions open scholarly website including Institutional Repository
- Deposit due to Funding Body, Institutional and Governmental mandate only allowed where separate agreement between repository and publisher exists
- Set statement to accompany deposit
- Published source must be acknowledged
- Must link to journal home page or articles' DOI
- Publisher's version/PDF cannot be used
- Articles in some journals can be made Open Access on payment of additional charge
- NIH Authors articles will be submitted to PMC after 12 months
- Authors who are required to deposit in subject repositories may also use Sponsorship Option
- Pre-print can not be deposited for The Lancet
-
Classification green
Publications in this journal
-
Article: Copper(II) mixed chelate compounds induce apoptosis through reactive oxygen species in neuroblastoma cell line CHP-212
[show abstract] [hide abstract]
ABSTRACT: In the present work we report the antiproliferative activity of Cu(II) coordination compounds, CasIIgly ([Cu(4,7-dimethyl-1,10-phenanthroline) (glycinato) (H2O)]NO3), CasIIIia ([Cu(4,4'-dimethyl-2,2'-bipyridine) (glycinato) (H2O)]NO3), and CasIIIEa ([Cu(4,7-dimethyl-1,10-phenanthroline) (acetylacetonato) (H2O)]NO3), against human tumoral cell line CHP-212 (estromal neuroblastoma). Additionally, the molecular structure of CasIIIEa was reported. The IC50 values obtained for the evaluated compounds are in the range 18 to 47 μM, representing an inhibition potency increase of 5 to 12 times compared with cisplatin (IC50 = 226.7 μM). After 2 h of incubation with the evaluated compounds, cells showed high levels of reactive oxygen species and a considerable GSH depletion, besides an important disruption of the mitochondrial membrane with release of cytochrome C and besides the presence of caspase-3, an effector caspase that is activated in the last step of apoptosis cascade. The results confirm that cell death in neuroblastoma CHP-212 treated with Casiopeínas occurs via apoptosis. Due the lack of expression of caspase-8, cell death is principally by the mitochondrial pathway. Thus, one of the most interesting findings of this work is the identification of a very important damage in neuroblastoma cells induced by Cu(II) coordination compounds in a very short exposition times.Journal of Inorganic Biochemistry 05/2013; -
Article: A QM/MM refinement of an experimental DNA structure with metal-mediated base pairs
Journal of Inorganic Biochemistry 03/2013; -
Article: Biological activity and cellular uptake of [Ru(η5-C5H5)(PPh3)(Me2bpy)][CF3SO3] complex
[show abstract] [hide abstract]
ABSTRACT: Anticancer activity of the new [Ru(η5-C5H5)(PPh3)(Me2bpy)][CF3SO3] (Me2bpy = 4,4′-dimethyl-2,2′-bipyridine) complex was evaluated in vitro against several human cancer cell lines, namely A2780, A2780CisR, HT29, MCF7, MDAMB231 and PC3. Remarkably, the IC50 values, placed in the nanomolar and sub-micromolar range, largely exceeded the activity of cisplatin. Binding to human serum albumin, either HSA (human serum albumin) or HSAfaf (fatty acid-free human serum albumin) does not affect the complex activity. Fluorescence studies revealed that the present ruthenium complex strongly quench the intrinsic fluorescence of albumin. Cell death by the [Ru(η5-C5H5)(PPh3)(Me2bpy)][CF3SO3] complex was reduced in the presence of endocytosis modulators and at low temperature, suggesting an energy-dependent mechanism consistent with endocytosis. On the whole, the biological activity evaluated herein suggests that the complex could be a promising anticancer agent.Journal of Inorganic Biochemistry 02/2013; 122(May 2013):8-17. -
Article: "[RuII(5-C5H5)(bipy)(PPh3)]+, a promising large spectrum antitumor agent: cytotoxic activity and interaction with Human Serum Albumin"
Journal of Inorganic Biochemistry 07/2012; -
Article: Cytotoxic copper(II), cobalt(II), zinc(II), and nickel(II) coordination compounds of clotrimazole
[show abstract] [hide abstract]
ABSTRACT: Sixteen novel mononuclear Cu(II), Co(II), Zn(II), and Ni(II) complexes of the biologically active ligand clotrimazole (clotri) of the form [M(clotri)2Cl2]•nH2O (1–4), [M(clotri)2Br2]•nH2O (5–7), [M(clotri)3Br2] (8), [M(clotri)3NO3]NO3•nH2O (9, 11), [M(clotri)3(NO3)2]•nH2O (10), and [M(clotri)3(OH2)2NO3]NO3•nH2O (12) were synthesized and fully characterized. Dinuclear [Cu2(clotri)4µ2-Cl4]•2H2O (1a) and [Cu2(clotri)4µ2-Br2]•2H2O (5b) as well as tetranuclear [Cu4(clotri)4µ4-Br6µ4-O] (5a) complexes were also isolated. Complexes 1‒7, 9, and 11 present a tetrahedral geometry; complex 8 exhibits a pentacoordinated structure; complexes 1a, 10 and 12 an octahedral geometry. X-Ray crystal structures of [Cu(clotri)2Cl2]•(1), [Cu(clotri)2(EtOH)Cl2]•(1•EtOH), [Zn(clotri)2Cl2] (3), [Zn(clotri)2Br2] (7), and [Cu4(clotri)4µ4-Br6µ4-O] (5a) were obtained. Complexes 1–12 were tested for cytotoxic activity against the human carcinoma cell lines HeLa (cervix-uterine), PC3 (prostate), and HCT-15 (colon) with IC50 values < 30 µM. Confocal microscopy and nuclear dying (DAPI) for complex 1 showed condensation of cromatin and nuclear membrane fragmentation. Immunocytochemical detection/expression of biomarkers suggests that complexes 1 and 9 induce cell death via apoptosis. TUNEL assay detected DNA fragmentation in HeLa cells, resulting from apoptotic signaling cascades induced by Cu(II) complexes 1 and 9. 1H NMR studies of the Zn(II) complexes showed that they can bind to nucleotides.Journal of Inorganic Biochemistry 05/2012; -
Article: DNA Conformation and Repair of Polymeric Natural DNA Damaged by Antitumor Azolato-Bridged Dinuclear PtII Complex
Journal of Inorganic Biochemistry 05/2012; -
Article: Overexpression, purification, and biochemical and spectroscopic characterization of coppercontaining nitrite reductase from Sinorhizobium meliloti 2011. Study of the interacti
Journal of Inorganic Biochemistry 04/2012; -
Article: Synthesis of organometallic ruthenium(II) complexes with strong activity against several human cancer cell lines
Journal of Inorganic Biochemistry 02/2012; -
Article: Ferraroni M., Matera I., Chernykh A., Kolomytseva M., Golovleva L., Scozzafava A., Briganti F. Reaction Intermediates and Redox State Changes in a Blue Laccase from Steccherinum ochraceum observed by Crystallographic High/Low X-Ray Dose Experiments. J Inorg Biochem, 2012, V. 111, pp. 203-209.
Journal of Inorganic Biochemistry 01/2012; -
Article: Diastereomerically Pure Platinum (II) Complexes as Antitumoral Agents. The influence of the mode of binding {(N),(N, O)< sup>-</sup> or (C, N)}< sup>-</sup> of (< i> 1S, 2R )< i>- [(η< sup> 5</sup>-C< sub> 5</sub> H< sub> 5</sub>) Fe {(η< sup> 5</sup>-C< sub> 5</sub> H< sub> 4</sub>)-CH= N-CH (Me)-CH (OH)-C< sub> 6</sub> H< sub> 5</sub>}] and the arrangement of the auxiliary ligands
Journal of Inorganic Biochemistry 01/2012; -
Article: Novel estradiol based metal complexes of Tc-99m
[show abstract] [hide abstract]
ABSTRACT: Aiming to contribute to the design of technetium imaging agents for estrogen receptor (ER) positive breast tumors, we have synthesized and evaluated the novel organometallic estradiol complexes (fac-[M(CO)3 (κ3-10)]+ and fac-[M(CO)3(κ3-12) M=Re/99mTc) using two different bifunctional tridentate ligands (4 and 8). The rhenium complexes (13 and 14) were fully characterized by IR, 1H NMR, 13C NMR, mass spectrometry and elemental analyses. The 99mTc complexes (15 and 16) were obtained with high radiochemical purity and exhibited high in vitro radiochemical stability. To get a first insight into the relevance of these complexes for targeting ER positive tumors, ER binding affinity assays and cellular internalization studies in an ER expressing cell line, MCF-7, have also been performed suggesting a non ER mediated uptakeJournal of Inorganic Biochemistry 01/2012; 111:1-9. -
Article: nataraj chitrapriya
Journal of Inorganic Biochemistry 01/2011; 105:1569. -
Article: Accumulation of Eu3+ chelates in cells expressing or not P-glycoprotein: implications for blood-brain barrier crossing
Journal of Inorganic Biochemistry 01/2010; 104(1):47-54. -
Article: Antiproliferative activity and QSAR study of copper(II) mixed chelate [Cu(N–N)(acetylacetonato)]NO3 and [Cu(N–N)(glycinato)]NO3 complexes, (Casiopeínas®)
Journal of Inorganic Biochemistry 01/2009; 103:299. -
Article: Oxindole-Schiff base copper(II) complexes interactions with human serum albumin: spectroscopic, oxidative damage, and computational studies
Journal of Inorganic Biochemistry 01/2009; 103:1331. -
Article: Dinuclear organoiridium(III) mono- and bis-intercalators with rigid bridging ligands: Synthesis, cytotoxicity and DNA binding
Journal of Inorganic Biochemistry 01/2009; 103(10):1405-1414.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.
Keywords
Related Journals
Developmental Neurobiology
John Wiley & Sons
ISSN: 1932-846X, Impact factor: 3.55
Current Medicinal Chemistry
Bentham Science Publishers
ISSN: 1875-533X, Impact factor: 4.86
The Journal of nutritional biochemistry
Elsevier
ISSN: 1873-4847, Impact factor: 4.29
Current topics in medicinal chemistry
Bentham Science Publishers
ISSN: 1873-4294, Impact factor: 4.47
FEBS letters
Elsevier
ISSN: 1873-3468, Impact factor: 3.54
Cancer letters
Elsevier
ISSN: 1872-7980, Impact factor: 4.86
Molecular Medicine Reports
ISSN: 1791-3004, Impact factor: 0.42
Oncology Reports
Ethnikon Hidryma Ereunōn (Greece)
ISSN: 1791-2431, Impact factor: 1.84